StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > SHOULDN'T BE GOING DOWN EVERY DAY

<< Previous

Bullboard Posts

Next >>

Comment by brad129on Feb 26, 2021 11:41am

76 Views

Post# 32671298

RE:RE:RE:RE:RE:SHOULDN'T BE GOING DOWN EVERY DAY

my memory recalls the "about 1 million" statement was on the second quarter conference call then we hit 1.5 for the full quarter gpe2005 is not lying to the board, just because something doesn't look good doesn't mean it is untrue. Most holders remember this I'm sure.

StockscoutX wrote: What kind of BS are you spewing gpe2005? "Not sure who the interview was". When you are not sure of something, it makes all your arguments not sure and totally inaccurate.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?